CSafe Global appoints Amy DuRoss as President, Cell and Gene Therapies
Continues investment in cell and gene therapy solutions
CSafe Global | 26/07/2022 | By Sudeep Soparkar | 237
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy